Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine

Clinica Chimica Acta

Volumn 317, Issue 1-2, 2002, Pages 85-92

  Li, Jin Heng ^a   Xu, Jing Qiu ^a   Cao, Xiao Mei ^a   Ni, Li ^a   Li, Yong ^a   Zhuang, Yi Yi ^a   Gong, Jian Bin ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Orosomucoid; Pharmacogenetics; Protein binding; Quinidine; Unbound drug

Indexed keywords

ALBUMIN; OROSOMUCOID; POLYACRYLAMIDE GEL; QUINIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; HALF LIFE TIME; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; HUMAN; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; LIVER METABOLISM; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; ULTRAFILTRATION;

ADULT; BLOOD PROTEINS; HETEROZYGOTE; HUMANS; MALE; OROSOMUCOID; POLYMORPHISM, GENETIC; QUINIDINE;

EID: 0036155217     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00763-X     Document Type: Article

References (27)

1. Quinidine
2. Total and free quinidine by fluorescence polarization immunoassay and comparison with high performance liquid chromatography
3. Pharmacokinetic and clinical implications of quinidine protein binding
4. Determination of free digoxin in sera of 8 patients with chronic cardiac insufficiency
5. 1-acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs
6. Therapeutic monitoring of antiarrhythmic drugs
7. Altered protein binding of quinidine in patients with atrial fibrillation and flutter
8. The plasma protein binding of basic drugs
9. Human orosomucoid polymorphism: Molecular basis of the three common ORM1 alleles, ORM1 * F1, ORM1 * F2, and ORM1 *S
10. Polymorphisms of alpha-1-acid (orosomucoid), alpha-2-HS-glycoproteins and alpha-1-B among the Parsis of India
11. Orosomucoid (ORM1) polymorphism in Arabs and Jews of Israel: More evidence for a Middle Eastern origin of the Jews
12. Genetic polymorphisms of orosomucoid on the Han population in Nanjing of China
13. Drug binding in plasma: A summary of recent trends in the study of drug and hormone binding
14. 1-acid glycoprotein
15. 1-acid glycoprotein concentrations in serum of male healthy subjects and age-related changes
16. Determination of quinidine concentrations in plasma by HPLC
17. Single dose pharmacokinetics study on latamoxef in normal volunteers
18. Lansoprazole pharmacokinetics in subjects with various degree of kidney function
19. Role of pharmacokinetics and metabolism in drug discovery and development
20. Determinants of plasma 1-acid glycoprotein (AAG) concentrations in health
21. Significance for determination of free drug concentration in therapeutic drug monitoring
22. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis
23. 1-acid glycoprotein
24. Interindividual differences in the binding of antidepressives to plasma proteins: The role of the variants of alpha1-acid glycoprotein
25. Binding of D-methadone, L-methadone to proteins in plasma of healthy volunteers
26. Changes in the binding capacity of alpha-1-acid glycoprotein in patients with renal insufficiency
27. Caucasian versus African-American differences in orosomucoid: Potential implications for therapy